Furthermore, coexistence of BRAFV600E and TERT or RAS and TERT mutations has been shown to be associated with higher recurrence rate and mortality both in PTC and FTC, while these variants independently have a modest effect (17). Here, TERT is linked to thyroid cancer, nonmedullary, 2.